Financial reports
20-F
2023 FY
Annual report (foreign)
5 Mar 24
20-F/A
2022 FY
Annual report (foreign) (amended)
17 Apr 23
20-F
2022 FY
Annual report (foreign)
10 Mar 23
20-F
2021 FY
Annual report (foreign)
8 Mar 22
20-F
2020 FY
Annual report (foreign)
12 Mar 21
20-F
2019 FY
Annual report (foreign)
6 Mar 20
20-F
2018 FY
Annual report (foreign)
15 Mar 19
20-F/A
2017 FY
Annual report (foreign) (amended)
20 Mar 18
20-F
2017 FY
Annual report (foreign)
16 Mar 18
20-F
2016 FY
Annual report (foreign)
17 Mar 17
Current reports
6-K
Us Fda Accepts New Indication Filing for Jemperli
24 Apr 24
6-K
Director/pdmr Shareholding
19 Apr 24
6-K
Director/pdmr Shareholding
17 Apr 24
6-K
Results from Long-term Data Relating to Shingrix
17 Apr 24
6-K
GSK Announces Additional EAGLE-1 Results
17 Apr 24
6-K
Amendment - Director/pdmr Shareholding
16 Apr 24
6-K
Fda Accepts GSK Meningitis Vaccine Candidate File
16 Apr 24
6-K
Director/pdmr Shareholding
15 Apr 24
6-K/A
Replacement - Total Voting Rights
4 Apr 24
6-K
Total Voting Rights
2 Apr 24
Registration and prospectus
F-3ASR
Automatic shelf registration (foreign)
25 Mar 24
25-NSE
Exchange delisting
2 Oct 23
POS AM
Prospectus update (post-effective amendment)
10 Mar 23
25-NSE
Exchange delisting
15 Sep 22
25-NSE
Exchange delisting
1 Sep 22
424B3
Prospectus supplement
17 May 22
424B3
Prospectus supplement
17 May 22
25-NSE
Exchange delisting
9 May 22
F-6EF
Automatic registration for ADRs (foreign)
6 May 22
25-NSE
Exchange delisting
2 May 22
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
5 Mar 24
SD
Conflict minerals disclosure
30 May 23
EFFECT
Notice of effectiveness
16 Mar 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
10 Mar 23
SD
Conflict minerals disclosure
27 May 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
8 Mar 22
UPLOAD
Letter from SEC
8 Sep 21
CORRESP
Correspondence with SEC
31 Aug 21
UPLOAD
Letter from SEC
18 Aug 21
SD
Conflict minerals disclosure
27 May 21
Ownership
SC 13D/A
Nkarta, Inc.
28 Mar 24
SC 13G/A
DODGE & COX
13 Feb 24
SC 13D/A
23andMe Holding Co.
9 Feb 24
SC 13G/A
CureVac N.V.
6 Feb 24
SC 13G/A
Wave Life Sciences Ltd.
6 Feb 24
4
Wave Life Sciences Ltd.
30 Jan 24
SC 13D/A
Haleon plc
19 Jan 24
SC 13D/A
Haleon plc
10 Oct 23
SC 13D/A
Haleon plc
11 Sep 23
SC 13D/A
BICYCLE THERAPEUTICS plc
20 Jul 23